China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Effect of Chiglitazar on Pancreatic Islet Function and Metabolism in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Open-Label Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131227
Registration Time: 2026/08/31
Type: Interventional study
Primary Sponsor: Tianjin Medical University General Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=319892
Published by HT Digital Content Services with permission from Health Daily Digest....